Century Therapeutics (IPSC) Return on Invested Capital (2022 - 2023)
Century Therapeutics' (IPSC) quarterly Return on Invested Capital came in at 0.11% in Q4 2023, up 3.0% year-on-year from 0.11% in Q4 2022, and down 48.38% on a QoQ basis from 0.07% in Q3 2023.
Century Therapeutics (IPSC) Return on Invested Capital (2022 - 2023) Analysis & Trends
Century Therapeutics (IPSC) has 2 years of Return on Invested Capital data on file, last reported at 0.11% in Q4 2023.
- On a quarterly basis, Return on Invested Capital rose 3.0% year-over-year to 0.11% in Q4 2023; TTM through Dec 2023 was 0.11%, a 3.0% increase from a year earlier, with the FY2022 full-year figure at 0.36%, down 18.0% from the prior year.
- Return on Invested Capital for Q4 2023 stood at 0.11%, down from 0.07% in the prior quarter.
- Over the last five years, Return on Invested Capital for IPSC reached as high as 0.06% in Q2 2023 and fell as low as 0.14% in Q4 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROIC (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 0.00% |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 0.04% |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Century Therapeutics | 419.84 Mn | 285.04 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | -0.11% |
| Sep 30, 2023 | -0.07% |
| Jun 30, 2023 | -0.06% |
| Mar 31, 2023 | -0.08% |
| Dec 31, 2022 | -0.14% |